Serratia marcescens osteomyelitis in an infant

Allergy and Asthma Proceedings

Volumn 27, Issue 6, 2006, Pages 544-548

  Mayer, Chad W ^a   Bangash, Shahid ^a   Bocchini Jr , Joseph A ^a   Lowery Nordberg, Mary ^b   Bahna, Sami L ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; ENTEROBACTER INFECTION; FEMALE; GENETIC LINKAGE; GENETICS; HETEROZYGOTE DETECTION; HUMAN; INFANT; MALE; MICROBIOLOGY; OSTEOMYELITIS; SERRATIA MARCESCENS; X CHROMOSOME;

FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HETEROZYGOTE DETECTION; HUMANS; INFANT; LINKAGE (GENETICS); MALE; OSTEOMYELITIS; SERRATIA INFECTIONS; SERRATIA MARCESCENS; X CHROMOSOME;

EID: 33845493456     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2006.27.2938     Document Type: Article

References (18)

1. Mckenna-Vozzelli K, and Gutman L. Osteomyelitis and suppurative arthritis. In Krugman's Infectious Diseases of Children, 11th ed. Gershon AA, Hotez PJ, and Katz SL (Eds). St. Louis, MO: Mosby, 403-414, 2004.
2. Roos D, and Curnutte J. Chronic granulomatous disease. In Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. Ochs HD, Smith CI, and Puck JM (Eds). New York: Oxford University Press, Inc., 353-374, 1999.
3. Matute JD, Arias AA, Dinauer MC, and Patino PJ. p40phox: The last NADPH oxidase subunit. Blood Cells Mol Dis 35:291-302, 2005.
4. Heyworth PG, Cross AR, and Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 15:578-584, 2003.
5. Goldblatt D, and Thrasher AJ. Chronic granulomatous disease. Clin Exp Immunol 22:1-9, 2000.
6. Jirapongsananuruk O, Malech HL, Kuhns DB, et al. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. J Allergy Clin Immunol 111:374-379, 2003.
7. Vowells SJ, Fleisher TA, Sekhsaria S, et al. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr 128:104-107, 1996.
8. Crockard AD, Thompson JM, Boyd NA, et al. Diagnosis and carrier detection of chronic granulomatous disease in five families by flow cytometry. Int Arch Allergy Immunol 114:144-152, 1997.
9. Rosenzweig SD, and Holland SM. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 113:620-626, 2004.
10. Van Bruggen R, Bautista JM, Petropoulou T, et al. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 100:1026-1030, 2002.
11. Gregg XT, and Prchal JT. Red blood cell enzymopathies. In Hematology: Basic Principles and Practice, 4th ed. Hoffman R, Benz EJ, Shattil SJ, et al. (Eds). Philadelphia: Churchill Livingston, 653-660, 2005.
12. Vives Corrons JL, Feliu E, and Pujades MA. Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: Description of a new molecular variant (G6PD Barcelona). Blood 59:428-434, 1982.
13. Schlegel RJ, and Bellanti JA. Increased susceptibility of males to infection. Lancet 2:826-827, 1969.
14. Bellanti JA, Cantz BE, and Schiegel RJ. Accelerated decay of glucose 6-phosphate dehydrogenase activity in chronic granulomatous disease. Pediatr Res 4:405-411, 1970.
15. Schlegel RJ, and Bellanti JA. Leucocyte G-6-PD deficiency and bactericidal activity. Lancet 1:677-678, 1970.
16. Erickson RP, Stites DP, Fudenburg HH, and Epstein CJ. Altered levels of glucose-6-phosphate dehydrogenase stabilizing factors in X-linked chronic granulomatous disease. J Lab Clin Med 80:644-653, 1972.
17. Ardati KO, Bajakian KM, and Tabbara KS. Effect of glucose-6-phosphate dehydrogenase deficiency on neutrophil function. Acta Haematol 97:211-215, 1997.
18. Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: A survey of the European experience, 1985-2000. Blood 100:4344-4350, 2002.